Gilead Sciences · 22 hours ago
Director, Marketing Sciences - HIV Treatment
San Francisco Bay Area
Full-time
Onsite
Director/Executive
$226K/yr - $293K/yr
10+ years expGilead Sciences is committed to creating a healthier world for all people and is seeking a Director, Marketing Sciences for HIV Treatment. This role involves providing insights into market dynamics, product performance, and collaborating with various teams to drive strategic decisions and manage team performance.
BiopharmaBiotechnologyHealth CareManufacturingPharmaceutical
Responsibilities
Forecasting: Leverage primary and secondary research insights and team inputs to design and build accurate, actionable, and evidenced based forecasting models. The forecaster will also produce analogues, formulate assumptions, and define opportunities and risks associated with the forecast
Performance Tracking: Develop and maintain a dashboard for tracking performance of each product. Develop a mechanism for identifying variations in performance vs. target, and gathering relevant data to help evaluate and determine next steps. Synthesize market dynamics to identify potential drivers impacting performance to inform marketing and sales decisions
Secondary Data Analysis: Define analytical priorities in collaboration with rest of the commercial organization. Ensure successful execution of secondary analytics projects and integrating results with primary market research and latest competitive intelligence into actionable insights
Collaboration: Partner closely with FP&A, supply chain and other corporate functions to design and execute an effective Kite S&OP process, to build and drive quarterly revenue reconciliation
Strategic Projects: Drive analytics for planned and ad hoc strategic projects including scenario analysis to help drive key decisions for the business
Team Management: Hire, manage and develop direct reports
Qualification
Required
12+ Years with BS/BA OR
10+ Years with MS/MA or MBA
Preferred
12+ years of relevant experience with Bachelor's Degree. MBA or other related graduate-level degree is a plus
6 or more years of work experience in forecasting, marketing sciences, market research, strategic consulting or other analytical work in the biotech / pharmaceutical industries in leadership roles with direct management experience
Previous experience in oncology/hematology is required
Track record of delivering actionable insights through successful execution of forecasting and marketing analytics projects, as well as strategic problem-solving skills
Exceptional ability to manage multiple projects in a fast-moving entrepreneurial environment, with changing priorities and significant time pressures
Strong communication skills (both verbal and written) required. Demonstrated ability to collaborate and work cross-functionally
Ability to develop and maintain strong team, including external partners, relationships while driving for positive results
Possess a willingness and ability to work hands-on and with a sense of urgency
Extensive proficiency with Microsoft Office (Word, Excel, PowerPoint and Outlook) and forecasting software (e.g., Crystal ball, Forecast Pro, customized platforms)
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
10001+ employees
H1B Sponsorship
Gilead Sciences has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (269)
2024 (241)
2023 (222)
2022 (208)
2021 (235)
2020 (187)
Funding
Current Stage
Public CompanyTotal Funding
$4.41BKey Investors
Abingworth
2024-11-13Post Ipo Debt· $3.5M
2024-02-29Post Ipo Equity· $210M
2023-09-07Post Ipo Debt· $2B
Leadership Team
Keeley Wettan
Senior Vice President, Legal
Patrick Loerch
Senior Vice President, Clinical Data Science
Recent News
2026-01-23
GlobeNewswire
2026-01-22
Company data provided by crunchbase